Abstract:MicroRNAs (miRNAs) constitute a family of small non-coding ribonucleic acids that are post-transcriptional regulators of messenger RNA (mRNA) complexity. While miRNAs are known to be dynamically regulated during CNS development, the roles of specific miRNAs in CNS aging and neurodegeneration are not well understood. This study examined miRNA abundance and signaling circuitry in Alzheimer's disease (AD) brain, in cytokine-, Aβ42- and ROS-stressed human neural primary cell lines and in Tg2576 transgenic mice fed a high-fat cholesterol (HFC) diet. AD and age-matched control post-mortem brain tissue; IL-1β, Aβ42 and ROS-stressed human neural (HN) cells in primary culture; high-fat cholesterol (HFC) diet stressed Tg2576 mice; total DNA, RNA and protein isolation and quality control; DNA arrays (Affymetrix, Santa Clara, CA); micro RNA (miRNA) arrays (LC Sciences, Houston, TX); miRNA panels; Northern analysis; RT-PCR; Western Immunoblotting; gel shift assay; miRNA construct transfection vectors; specific NF–κB and inflammatory transcription factor repression; bioinformatics (Sanger miRBASE, Cambridge UK). Of the total number of miRNAs expressed in the human brain, only a selective subset appear to be altered in the AD process. miRNAs encoding miR-9, miR-124a, miR-125b, miR-128, miR-132 and miR-219 were found to be abundantly represented in fetal hippocampus however they exhibited differential regulation in Alzheimer hippocampus. Specific increases in the abundance of miRNA-146a was found to coincide with down-regulation in the abundance of one prominent miRNA-146a target, complement factor H (CFH) mRNA, encoding an important regulatory glycoprotein in the brain's complement and inflammatory response. Promoter mapping, inhibitor studies and transfection-reporter studies showed that miRNA-146a is an NF–κB-sensitive gene. We also observed a specific up-regulation of miRNA-146a in cytokine IL-1β- and Aβ42-stressed human neural cells and in HFC-stressed Tg2576 mice, an effect that was reversed in part by the cholesterol biosynthesis inhibitor simvastatin. These data are consistent with the idea that altered miRNA-mediated processing of mRNA populations may contribute to atypical mRNA abundance, neural dysfunction and inflammatory signaling pathways in Alzheimer's disease. The use of anti-miRNA pharmacotherapeutic strategies are attractive because they have potential to silence entire families of pro-inflammatory pathogenic genes in Alzheimer's disease brain. Supported in part by NIA AG18031.

P3‐046: Understanding Brain Microrna Profiling in the Double Transgenic APP/PS1 Mouse Model of Alzheimer's Disease

Genome-wide Analysis of Mirna Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.

MicroRNA-139 Modulates Alzheimer's-associated Pathogenesis in SAMP8 Mice by Targeting Cannabinoid Receptor Type 2.

O2-03-06: Micro RNA-146A–mediated Signaling in Alzheimer's Disease

Down‐regulated Expression of Microrna‐338‐5p Contributes to Neuropathology in Alzheimer's Disease

Expression of tiRNA and tRF in APP/PS1 transgenic mice and the change of related proteins expression

MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice.

Identification of potential therapeutic and diagnostic characteristics of Alzheimer disease by targeting the miR-132-3p/FOXO3a-PPM1F axis in APP/PS1 mice

Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.

Identification of Circulating Mir-125B As a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse

Multiple Inflammatory Profiles of Microglia and Altered Neuroimages in APP/PS1 Transgenic AD Mice.

Sponging of mirna-146a using aav-anti-mirna-146a-vectors mediates synaptic and amyloidogenic neuropathology and cognitive deficits in a 5xfad murine model of alzheimer’s disease

miR-146a-5p Modulates Adult Hippocampal Neurogenesis Deficits Through Klf4/p-Stat3 Signaling in APP/PS1 Mice

In-depth transcriptomic analyses of LncRNA and mRNA expression in the hippocampus of APP/PS1 mice by Danggui-Shaoyao-San

Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer’s disease

MicroRNA-135a and -200B, Potential Biomarkers for Alzheimer׳s Disease, Regulate Β Secretase and Amyloid Precursor Protein.

Identification and drug-induced reversion of molecular signatures of Alzheimer’s disease onset and progression in AppNL-G-F, AppNL-F, and 3xTg-AD mouse models

MicroRNA-338-5p Alleviates Neuronal Apoptosis Via Directly Targeting BCL2L11 in APP/PS1 Mice

MicroRNA-668-3p regulates oxidative stress and cell damage induced by Aβ1-42 by targeting the OXR1/p53-p21 axis

Folic Acid Deficiency Enhances Abeta Accumulation in APP/PS1 Mice Brain and Decreases Amyloid-Associated Mirnas Expression

iTRAQ-based Proteomic Analysis of APPSw,Ind Mice Provides Insights into the Early Changes in Alzheimer's Disease.